These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3897967)

  • 1. [Cefmenoxime diffusion into cerebrospinal fluid during human purulent meningitis].
    Stahl JP; Croize J; Bru JP; Pegourie B; Blanc-Jouvan F; Bryskier A; Micoud M
    Pathol Biol (Paris); 1985 May; 33(5):365-7. PubMed ID: 3897967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of cefmenoxime into cerebrospinal fluid of patients with bacterial meningitis.
    Humbert G; Veyssier P; Fourtillan JB; Bryskier A; Borsa F; Lallement PY; Bonmarchand G
    J Antimicrob Chemother; 1986 Oct; 18(4):503-6. PubMed ID: 3464585
    [No Abstract]   [Full Text] [Related]  

  • 3. Penetration of cefmenoxime in the CSF as compared to cefotaxime in a small series of cases.
    Cherubin C; Nair SR
    J Antimicrob Chemother; 1984 Apr; 13(4):401-2. PubMed ID: 6327601
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of cefmenoxime in experimental Escherichia coli bacteremia and meningitis.
    Kim KS
    Antimicrob Agents Chemother; 1985 Sep; 28(3):389-92. PubMed ID: 3907491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Penetration of ceftizoxime (FK 749) into the cerebrospinal fluid (author's transl)].
    Ruf B
    Infection; 1982; 10(2):76-80. PubMed ID: 6284650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study on transference of cefmenoxime into the cerebrospinal fluid].
    Shibata Y; Nogaki H; Ishida K; Kawaguchi T
    Jpn J Antibiot; 1985 Jan; 38(1):45-8. PubMed ID: 3857362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cefmenoxime concentrations in cerebral ventricles during systemic treatment of Pseudomonas stutzeri ventriculitis].
    Veyssier P; Lallement PY; Devillers A; Kaloustian E; Darchis JP; Bryskier A
    Presse Med; 1985 Mar; 14(13):747. PubMed ID: 3157982
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacokinetics of cefmenoxime in the aged subject (60 to 90 years of age) after an intravenous injection of 1 g].
    Veyssier P; Bryskier A; Modai J; Boquet A; Fourtillan JB
    Pathol Biol (Paris); 1986 Dec; 34(10):1081-3. PubMed ID: 3547264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cerebrospinal fluid diffusion kinetics of cefotaxime and fosfomycin in Staphylococcus aureus meningitis with otorrhea].
    Tremeaux JC; Portier H; Sautreaux JL; Pechinot A; Kazmierczak A
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):556-8. PubMed ID: 6087251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diffusion of fosfomycin into the cerebrospinal fluid in purulent meningitis].
    Stahl JP; Croize J; Bru JP; Girard-Blanc MF; François P; Gaillat J; Micoud M
    Presse Med; 1984 Dec; 13(44):2693-5. PubMed ID: 6240034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transplacental passage of cefmenoxime].
    Berthelot G; Bergogne-Berezin E; Ravina JH; Vernant D; Bryskier A
    Pathol Biol (Paris); 1984 May; 32(5):322-5. PubMed ID: 6330644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose plasma and cerebrospinal fluid pharmacokinetics of ceftriaxone in infants and children.
    Reed MD; Rekate HL; Aronoff SC; Myers CM; Blumer JL
    Clin Pharm; 1983; 2(6):558-63. PubMed ID: 6317277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefotaxime diffusion into cerebrospinal fluid of children with meningitis.
    Asmar BI; Thirumoorthi MC; Buckley JA; Kobos DM; Dajani AS
    Antimicrob Agents Chemother; 1985 Jul; 28(1):138-40. PubMed ID: 4037772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fundamental and clinical evaluations of cefmenoxime in the field of pediatrics].
    Kobayashi Y; Haruta T; Ookura K; Kuroki S; Tsutsui T
    Jpn J Antibiot; 1982 Nov; 35(11):2555-68. PubMed ID: 6302337
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bacteriologic, clinical and kinetic evaluation of cefmenoxime (SCE 1365) in the treatment of 68 cases of septicemia. A multicenter trial].
    Bryskier A; Sollet JP; Bleichner G; Segrestaa JM; Guerin JM; Dureux JB; Canton P; Veyssier P; Lallement PY; Mottin J
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):547-51. PubMed ID: 6087250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of purulent meningitis with ceftriaxone].
    Guggenbichler JP; Parth J
    Wien Med Wochenschr Suppl; 1985; 87():12-6. PubMed ID: 3856970
    [No Abstract]   [Full Text] [Related]  

  • 17. The penetration of cefmenoxime into cerebrospinal fluid across non-inflamed meninges.
    Rolston KV; Chandrasekar PH; Smith BR; LeFrock JL
    J Antimicrob Chemother; 1983 Nov; 12(5):519-21. PubMed ID: 6323372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefotaxime in treatment of meningitis and ventriculitis? Evaluation of drug concentrations in human cerebrospinal fluid.
    Brückner O; Collmann H; Hoffmann HG
    Intensive Care Med; 1982 Jan; 8(1):33-8. PubMed ID: 6276458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cerebrospinal fluid pharmacokinetics and treatment of bacterial meningitis with ceftizoxime.
    Cable D; Edralin G; Overturf GD
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():121-7. PubMed ID: 6295997
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of purulent meningitis in the child using Cefotaxime].
    Borderon JC; Despert F; Santini JJ; Laugier J
    Pediatrie; 1985 Jun; 40(4):291-9. PubMed ID: 3909093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.